WY-41195

[Na+].CNC1=C(C#N)C(NC(=O)C([O-])=O)=CC=C1

InChIKey=FWVLHWWSLPWDCF-UHFFFAOYSA-M

InChI=1S/C10H9N3O3.Na/c1-12-7-3-2-4-8(6(7)5-11)13-9(14)10(15)16;/h2-4,12H,1H3,(H,13,14)(H,15,16);/q;+1/p-1

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
The topical effects of Wy-41,195 [2-cyano-3-(methylamino)phenylamino] oxoacetic acid, sodium salt and disodium cromoglycate in the rat passive eyelid anaphylaxis.	1985	3917983
The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent.	1982	6186261

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:59:39 GMT 2025` Edited by `admin` on `Mon Mar 31 19:59:39 GMT 2025`
Record UNII	WH6C1NTP45
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

WY-41195

Common Name

English

ACETIC ACID, ((2-CYANO-3-(METHYLAMINO)PHENYL)AMINO)OXO-, MONOSODIUM SALT

Preferred Name

English

Code System Code Type Description

PUBCHEM

23689136

Created by admin on Mon Mar 31 19:59:39 GMT 2025 , Edited by admin on Mon Mar 31 19:59:39 GMT 2025

PRIMARY

FDA UNII

WH6C1NTP45

Created by admin on Mon Mar 31 19:59:39 GMT 2025 , Edited by admin on Mon Mar 31 19:59:39 GMT 2025

PRIMARY

EPA CompTox

DTXSID10979511

Created by admin on Mon Mar 31 19:59:39 GMT 2025 , Edited by admin on Mon Mar 31 19:59:39 GMT 2025

PRIMARY

CAS

63365-44-6

Created by admin on Mon Mar 31 19:59:39 GMT 2025 , Edited by admin on Mon Mar 31 19:59:39 GMT 2025

PRIMARY